Basecare Medical to Review 1H 2026 Results and Potential Interim Dividend on 28 August 2026

Bulletin Express
08/18

Suzhou Basecare Medical Corporation Limited (Basecare Medical) has scheduled a board meeting for 28 August 2026. According to the company’s announcement dated 18 August 2026, directors will consider and approve the consolidated interim results for the six months ended 30 June 2026 and discuss the declaration of an interim dividend, if any.

The meeting will also address other routine board matters. Basecare Medical’s board currently comprises eight directors, including three executive directors, two non-executive directors and three independent non-executive directors.

The announcement was signed by Chairman and General Manager Dr. Liang Bo in Suzhou, PRC.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10